Taurine in cardiovascular disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 1, 2011, Pages 57-60

  Zulli, Anthony ^a  

^a VICTORIA UNIVERSITY   (Australia)

Author keywords

Atherosclerosis; Cholesterol; Coronary artery disease; Homocysteine; Hypertension

Indexed keywords

TAURINE;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIETARY INTAKE; DRUG EFFECT; HEART INFARCTION; HEART PROTECTION; HUMAN; NONHUMAN; RISK REDUCTION; SEA FOOD;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; DIET, MEDITERRANEAN; HUMANS; HYPOCHLOROUS ACID; SEAFOOD; TAURINE;

ANIMALIA;

EID: 79851515307     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328340d863     Document Type: Article

References (27)

1. Sofi F. The Mediterranean diet revisited: evidence of its effectiveness grows. Curr Opin Cardiol 2009; 24:442-446.
2. Martinez-Gonzalez MA, Bes-Rastrollo M, Serra-Majem L, et al. Mediterranean food pattern and the primary prevention of chronic disease: recent developments. Nutr Rev 2009; 67 (Suppl 1):S111-S116.
3. Wojcik OP, Koenig KL, Zeleniuch-Jacquotte A, et al. The potential protective effects of taurine on coronary heart disease. Atherosclerosis 2010; 208:19-25.
4. Berger AJ, Alford K. Cardiac arrest in a young man following excess consumption of caffeinated 'energy drinks'. Med J Aust 2009; 190:41-43.
5. Worthley MI, Prabhu A, De Sciscio P, et al. Detrimental effects of energy drink consumption on plateletand endothelial function. Am J Med 2010; 123:184-187.
6. Energy drinks: behind the buzz. Consum Rep 2007; 72:6.
7. Hoffman JR, Faigenbaum AD, Ratamess NA, et al. Nutritional supplementation and anabolic steroid use in adolescents. Med Sci Sports Exerc 2008; 40:15-24.
8. Hu J, Xu X, Yang J, et al. Antihypertensive effect of taurine in rat. Adv Exp Med Biol 2009; 643:75-84.
9. El Mesallamy HO, El-Demerdash E, Hammad LN, El Magdoub HM. Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance. Diabetol Metab Syndr 2010; 2:46.
10. Zulli A, Lau E, Wijaya BP, et al. High dietary taurine reduces apoptosis and atherosclerosis in the left main coronary artery: association with reduced CCAAT/enhancer binding protein, homologous protein and total plasma homocysteine but not lipidemia. Hypertension 2009; 53:1017-1022.
11. Ahn CS. Effect of taurine supplementation on plasma homocysteine levels of the middle-aged Korean women. Adv Exp Med Biol 2009; 643:415-422.
12. Murakami S, Sakurai T, Toda Y, et al. Prevention of neointima formation by taurine ingestion after carotid balloon injury. Vascul Pharmacol 2010; 53:177-184.
13. Wesseling S, Koeners MP, Joles JA. Taurine: red bull or red herring? Hypertension 2009; 53:909-911.
14. Ito T, Kimura Y, Uozumi Y, et al. Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 2008; 44:927-937.
15. Azuma J, Sawamura A, Awata N, et al. Therapeutic effect of taurine in congestive heart failure: a double-blind crossover trial. Clin Cardiol 1985; 8:276-282. (Pubitemid 15037650)
16. Azuma J, Sawamura A, Awata N. Usefulness of taurine in chronic congestive heart failure and its prospective application. Jpn Circ J 1992; 56:95-99.
17. Li Y, Arnold JM, Pampillo M, et al. Taurine prevents cardiomyocyte death by inhibiting NADPH oxidase-mediated calpain activation. Free Radic Biol Med 2009; 46:51-61.
18. Ghosh J, Das J, Manna P, Sil PC. Taurine prevents arsenic-induced cardiac oxidative stress and apoptotic damage: role of NF-kappa B, p38 and JNK MAPK pathway. Toxicol Appl Pharmacol 2009; 240:73-87.
19. Ito T, Muraoka S, Takahashi K, et al. Beneficial effect of taurine treatment against doxorubicin-induced cardiotoxicity in mice. Adv Exp Med Biol 2009; 643:65-74.
20. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320:365-376. (Pubitemid 19106873)
21. Hazell LJ, Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem J 1993; 290 (Pt 1):165-172. (Pubitemid 23081215)
22. Panzenboeck U, Raitmayer S, Reicher H, et al. Effects of reagent and enzymatically generated hypochlorite on physicochemical and metabolic properties of high density lipoproteins. J Biol Chem 1997; 272:29711-29720. (Pubitemid 27508065)
23. Stanley NR, Pattison DI, Hawkins CL. Ability of hypochlorous acid and N-chloramines to chlorinate DNA and its constituents. Chem Res Toxicol 2010; 23:1293-1302.
24. Hazell LJ, Stocker R. Alpha-tocopherol does not inhibit hypochlorite-induced oxidation ofapolipoprotein B-100 oflow-densitylipoprotein. FEBS Lett 1997; 414:541-544. (Pubitemid 27390663)
25. Schuller-Levis GB, Park E. Taurine and its chloramine: modulators of immunity. Neurochem Res 2004; 29:117-126. (Pubitemid 38181705)
26. Marcinkiewicz J, Grabowska A, Bereta J, Stelmaszynska T. Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J Leukoc Biol 1995; 58:667-674. (Pubitemid 26033855)
27. YusufS, Sleight P, Pogue J, et al. Effects ofan angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342:145-153.